Conjugated proteins with prolonged in vivo efficacy

Details Conjugated proteins with prolonged in vivo efficacy Conjugated proteins with prolonged in vivo efficacy

A - Human Necessities

61

K

A61K 47/48 (2006.01) A61P 7/04 (2006.01)

Patent

CA 2733200

The invention relates to conjugated proteins, in particular but not exclusively, blood coagulation factors, to processes for preparing said conjugates, to pharmaceutical compositions comprising said conjugates and to the use of the conjugates in therapy, in particular but not exclusively, for the treatment of diseases alleviated by blood coagulation factors such as the prophylactic treatment of hemophilia.

L'invention porte sur des protéines conjuguées, en particulier mais de manière non exclusive, sur des facteurs de coagulation sanguine, sur des procédés de préparation desdits conjugués, sur des compositions pharmaceutiques renfermant lesdits conjugués et sur l'utilisation des conjugués en thérapie, en particulier mais de manière non exclusive, dans le traitement de maladies soulagées par les facteurs de coagulation sanguine, par exemple le traitement prophylactique de l'hémophilie.

Affiliated with

Also associated with

Rating

Conjugated proteins with prolonged in vivo efficacy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Conjugated proteins with prolonged in vivo efficacy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugated proteins with prolonged in vivo efficacy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1359822